Article

Introducing the CRISPR/Cas9 cytosine base editor toolbox ‘LeishBASEedit’ - Gene editing…

medRxiv · 2022 · Beneke, T.; Engstler, M.

Key facts

Title Introducing the CRISPR/Cas9 cytosine base editor toolbox ‘LeishBASEedit’ - Gene editing and high-throughput screening in Leishmania without requiring DNA double-strand breaks, homologous recombination or donor DNA
First author Beneke, T.; Engstler, M.
Journal medRxiv
Published Dec 8, 2022
DOI 10.1101/2022.12.08.519658
Devices mentioned BK110039
Product codes mentioned KIP, KIT, NJT, PFT, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature